🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPsychological & BehavioralFood funeral grief — July 2024

Food funeral grief — July 2024

TomTeleRx Fri, Feb 13, 2026 at 2:22 AM 10 replies 856 viewsPage 1 of 2
TomTeleRx
Member
189
678
Feb 2025
Delaware
Feb 13, 2026 at 2:22 AM#1

A reference post rather than a discussion. Corrections are the point; I would rather this be right than mine. It is about mood and mental health, and it is deliberately narrow — everything I am not confident about is marked as such.

What is actually established

The mental-health dimension is under-measured in the trial literature and the reports here are consistent enough to take seriously. On the positive side: reduced anxiety around food, better self-image, more confidence. On the difficult side: grief for the years lost, identity disruption, relationships built around eating, and the loss of food as a coping mechanism with nothing put in its place. Rarer but real: anhedonia and emotional flatness. Regulators have started asking for validated patient-reported outcomes in this class; the existing data gap is not evidence of absence.

The condition it depends on

For anyone with an eating-disorder history this needs a clinician in the loop rather than a forum. The same drug can be therapeutic in binge-eating disorder and actively harmful in a restrictive disorder.

What I am not sure about

What would genuinely help is knowing how people separated a drug effect from the ordinary consequences of a large deficit and disrupted sleep, because I cannot. Practical detail welcome, however dull — the duller the better.

— TomTeleRx · corrections welcome and will be edited into this post with credit
12 7pete_manc_UK, anna.melb_AU, mark_tokyo and 9 others
Reply Quote Save Share Report
LarryQC_SD
Senior Member
2,123
9,876
Jan 2024
San Diego, CA
Feb 13, 2026 at 4:22 AM#2
TomTeleRx said:
The mental-health dimension is under-measured in the trial literature and the reports here are consistent enough to take seriously.
TomTeleRx said:
...mental health should only be used alongside therapy...

I'd say therapy should be AVAILABLE to all GLP-1 patients, but requiring it as a precondition for treatment would create an access barrier.

Not everyone can afford therapy. Not everyone needs it. Some people do just fine with medication + lifestyle changes. But for those with emotional eating, body image issues, or disordered eating history, therapy is extremely valuable.

My recommendation: make mental health screening part of the initial assessment, offer therapy as a recommended adjunct, but don't gatekeep medication access behind it.

Last edited: Feb 13, 2026 at 5:22 AM
11 6paul_denver, TinaHashiRN, robert_kc and 8 others
Reply Quote Save Share Report
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Feb 13, 2026 at 6:22 AM#3
TomTeleRx said:
The mental-health dimension is under-measured in the trial literature and the reports here are consistent enough to take seriously.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. I would be careful about how confidently the flatness reports get attributed. Rapid weight loss, a large deficit and disrupted sleep produce low mood on their own, and separating that from a drug effect is genuinely hard.

10 5paul_denver, TinaHashiRN, robert_kc and 7 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Feb 13, 2026 at 8:22 AM#4
SarahChen_PharmD said:
I would be careful about how confidently the flatness reports get attributed.

When to call your doctor about mental health side effects — a reference I wish I'd had:

Call immediately:

  • Severe abdominal pain (could be pancreatitis)
  • Vision changes (thyroid concern)
  • Lump in neck (thyroid nodule)
  • Severe vomiting/can't keep fluids down for 24h+

Schedule an appointment:

  • Persistent nausea beyond 4 weeks
  • Significant hair loss
  • Mood changes or depression
  • Gallbladder symptoms (RUQ pain after eating)
9 4carl_compliance, DanielChem_CHI, marco_milano and 6 others
Reply Quote Save Share Report
carlos_SATX
Member
245
1,123
Oct 2024
San Antonio, TX
Feb 13, 2026 at 8:17 PM#5
LarryQC_SD said:
TomTeleRx said: ...mental health should only be used alongside therapy...

Can confirm. Same sequence, different timescale.

8 3tommy_boulder, hyun_seoul, jim_asheville and 5 others
Reply Quote Save Share Report

Similar Threads

The neuroscience of "food noise" reduction on GLP-119 replies
Body dysmorphia after significant weight loss — seeking support19 replies
GLP-1 and addiction pathways — dopaminergic modulation evidence18 replies
Eating disorder history and GLP-1 therapy — clinical considerations7 replies
Quality of life improvements on GLP-1 — IWQOL-Lite data18 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register